Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein

Cytokine

Volumn 53, Issue 1, 2011, Pages 74-83

  Hasegawa, Haruki ^a   Thomas, Heather J ^a   Schooley, Ken ^a   Born, Teresa L ^a  

^a AMGEN INC   (United States)

Author keywords

Endocytic pathway; Epithelial cells; IL 32; Non classical secretion

Indexed keywords

CELL MARKER; DETERGENT; FAT DROPLET; GAMMA INTERFERON; INTERLEUKIN 32; ISOPROTEIN; PROTEINASE K; TRITON X 114; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOLOGICAL ACTIVITY; CELL COMPARTMENTALIZATION; CELL DEATH; CELL FRACTIONATION; CELL STIMULATION; CELL STRAIN HT29; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DENSITY GRADIENT CENTRIFUGATION; ENDOSOME; EXOSOME; HYDROPHOBICITY; IMMUNOFLUORESCENCE MICROSCOPY; INTESTINE EPITHELIUM CELL; INTRACELLULAR SIGNALING; LIPID MEMBRANE; LYSOSOME MEMBRANE; MEMBRANE STRUCTURE; MEMBRANE VESICLE; MOLECULAR WEIGHT; PHASE PARTITIONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; TONOPLAST;

CELL COMPARTMENTATION; DETERGENTS; ENDOCYTOSIS; ENDOPEPTIDASE K; EPITHELIAL CELLS; HT29 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTERFERON-GAMMA; INTERLEUKINS; INTESTINES; INTRACELLULAR MEMBRANES; LIPIDS; MEMBRANE PROTEINS; MOLECULAR WEIGHT; PROTEIN ISOFORMS; PROTEIN TRANSPORT; SECRETORY PATHWAY; SECRETORY VESICLES; SUBCELLULAR FRACTIONS; SURFACE PROPERTIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78349311836     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.09.002     Document Type: Article

References (39)

1. Dahl C.A., Schall R.P., He H.L., Cairns J.S. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992, 148:597-603.
2. Kim S.-H., Han S.-Y., Azam T., Yoon D.-Y., Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFα. Immunity 2005, 22:131-142.
3. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Walsh M., Park J.S., et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005, 102:16309-16314.
4. Joosten L.A.B., Netea M.G., Kim S.-H., Yoon D.-Y., Oppers-Walgreen B., Radstake T.R.D., et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103:3298-3303.
5. Shoda H., Fujio K., Yamaguchi Y., Okamoto A., Sawada T., Kochi Y., et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 2006, 8:R166.
6. Kobayashi H., Huang J., Ye F., Shyr Y., Blackwell T.S., Lin P.C. Interleukin-32β propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS ONE 2010, 5:e9458.
7. Dinarello C.A., Kim S.H. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006, 65:iii61-iii64.
8. Goda C., Kanaji T., Kanaji S., Tanaka G., Arima K., Ohno S., et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 2006, 18:233-240.
9. Netea M.G., Azam T., Lewis E.C., Joosten L.A., Wang M., Langenberg D., et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 2006, 3:e277.
10. Nold-Petry C.A., Nold M.F., Zepp J.A., Kim S.H., Voelkel N.F., Dinarello C.A. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci USA 2009, 106:3883-3888.
11. Shioya M., Nishida A., Yagi Y., Ogawa A., Tsujikawa T., Kim-Mitsuyama S., et al. Epithelial overexpression of interleukin-32α in inflammatory bowel disease. Clin Exp Immunol 2007, 149:480-486.
12. Kobayashi H., Lin P.C. Molecular characterization of IL-32 in human endothelial cells. Cytokine 2009, 46:351-358.
13. Nishida A., Andoh A., Shioya M., Kim-Mitsuyama S., Takayanagi A., Fujiyama Y. Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2008, 294:G831-G838.
14. Nishimoto K.P., Laust A.K., Nelson E.L. A human dendritic cell subset receptive to the Venezuelan equine encephalitis virus-derived replicon particle constitutively expresses IL-32. J Immunol 2008, 181:4010-4018.
15. Carter K.L., Cahir-McFarland E., Kieff E. Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J Virol 2002, 76:10427-10436.
16. Li W., Liu Y., Mukhtar M.M., Gong R., Pan Y., Rasool S.T., et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS ONE 2008, 3:e1985.
17. Li W., Yang F., Liu Y., Gong R., Liu L., Feng Y., et al. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol 2009, 39:1019-1024.
18. Rasool S.T., Tang H., Wu J., Li W., Mukhtar M.M., Zhang J., et al. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett 2008, 117:161-167.
19. Calabrese F., Baraldo S., Bazzan E., Lunardi F., Rea F., Maestrelli P., et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178:894-901.
20. Marcondes A.M., Mhyre A.J., Stirewalt D.L., Kim S.H., Dinarello C.A., Deeg H.J. Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc Natl Acad Sci USA 2008, 105:2865-2870.
21. Mhyre A.J., Marcondes A.M., Spaulding E.Y., Deeg H.J. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD. Blood 2009, 113:649-658.
22. Mun S.H., Kim J.W., Nah S.S., Ko N.Y., Lee J.H., Kim J.D., et al. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum 2009, 60:678-685.
23. Edwards C.J., Feldman J.L., Beech J., Shields K.M., Stover J.A., Trepicchio W.L., et al. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol Med 2007, 13:40-58.
24. Zrioual S., Ecochard R., Tournadre A., Lenief V., Cazalis M.-A., Miossec P. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 2009, 182:3112-3120.
25. Cagnard N., Letourneur F., Essabbani A., Devauchelle V., Mistou S., Rapinat A., et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005, 16:289-292.
26. Ford T., Graham J., Rickwood D. Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients. Anal Biochem 1994, 220:360-366.
27. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 1981, 256:1604-1607.
28. Harashima A., Toraya T., Okochi A., Yamamoto M., Suzuki M., Otani T., et al. Interleukin-8 and RANTES are signature cytokines made by HOZOT, a new type of regulatory T cells. Mol Immunol 2009, 46:3310-3319.
29. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009, 119:3573-3585.
30. Netea M.G., Lewis E.C., Azam T., Joosten L.A.B., Jaekal J., Bae S.-Y., et al. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci 2008, 105:3515-3520.
31. Mabilleau G., Sabokbar A. Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. PLoS ONE 2009, 4:e4173.
32. Nickel W., Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009, 10:148-155.
33. Pizzirani C., Ferrari D., Chiozzi P., Adinolfi E., Sandona D., Savaglio E., et al. Stimulation of P2 receptors causes release of IL-1{beta}-loaded microvesicles from human dendritic cells. Blood 2007, 109:3856-3864.
34. Andrei C., Margiocco P., Poggi A., Lotti L.V., Torrisi M.R., Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc Natl Acad Sci USA 2004, 101:9745-9750.
35. MacKenzie A., Wilson H.L., Kiss-Toth E., Dower S.K., North R.A., Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001, 15:825-835.
36. Luthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
37. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28:367-388.
38. Van Niel G., Raposo G., Candalh C., Boussac M., Hershberg R., Cerf-Bensussan N., et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001, 121:337-349.
39. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C.A., Kim S.-H. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 2006, 103:3316-3321.